Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer

Breast cancer is the most commonly diagnosed cancer (estimated 2.3 million new cases in 2020) and the leading cause of cancer death (estimated 685,000 deaths in 2020) in women globally. Breast cancers have been categorized into four major molecular subtypes based on the immunohistochemistry (IHC) ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Chenyi, Wang, Peipei, He, Siqi, Zhu, Jingjing, Shi, Yuanyuan, Wang, Jianxun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251310/
https://www.ncbi.nlm.nih.gov/pubmed/35795050
http://dx.doi.org/10.3389/fonc.2022.919072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251310/
https://www.ncbi.nlm.nih.gov/pubmed/35795050
http://dx.doi.org/10.3389/fonc.2022.919072

Ejemplares similares